CPHI China 2024 Successfully Concluded, ECHEMI Demonstrated Industry Leadership

On June 21, 2024, the 3-day 2024 CPHI China exhibition (CPHI China 2024) concluded successfully at the Shanghai New International Expo Center. This exhibition gathered medical and pharmaceutical elites from around the world, as well as many renowned enterprises, jointly witnessing and driving the thriving development of the pharmaceutical industry. As one of the most closely watched exhibitors, ECHEMI (booth numbers W3A32 & E5G106) performed exceptionally well at the exhibition, not only fully demonstrating its strong product strength and service capabilities, but also successfully hosting the much-anticipated BOSS STORY dialogue event on the last day of the exhibition, winning widespread acclaim from the on-site audience.

济南立德医药技术

诺泰生物

As a well-known professional exhibition in the domestic and international pharmaceutical field, CPHI China has been successfully held for the 22nd time, becoming an important bridge for pharmaceutical companies to exchange and collaborate. This session of the exhibition was grand in scale, with an exhibition area of over 210,000 square meters, attracting more than 3,500 domestic and foreign exhibiting companies and over 90,000 professional visitors. The exhibits covered the entire pharmaceutical industry chain, from natural extracts to pharmaceutical machinery, from active pharmaceutical ingredients to formulations, fully demonstrating the innovation and development of the pharmaceutical industry. In addition, more than 100 professional conferences and forums were held concurrently, providing exhibitors and visitors with rich opportunities for exchange and learning.

At this exhibition, ECHEMI showcased its extensive product line and high-quality services at the W3A32 and E5G106 booths. The on-site audience was endless, many of whom stopped to consult and negotiate cooperation. To expand its brand influence, ECHEMI also carefully prepared over a thousand copies of English-language pharmaceutical industry magazines, which were distributed free of charge to the on-site audience, to demonstrate its leading position and profound insights in the pharmaceutical industry.

It is worth mentioning that on the last day of the exhibition, ECHEMI successfully held the BOSS STORY dialogue event. During the event, ECHEMI's management and well-known figures in the industry had an in-depth exchange on topics such as chemical exports, pharmaceutical company development, global market trends, and future layouts. The atmosphere on-site was lively, with the audience actively participating in the interaction, and the event was a complete success. This activity not only demonstrated ECHEMI's professional strength in the pharmaceutical industry, but also further enhanced its brand image and reputation.

Through the grand exhibition of CPHI China 2024, ECHEMI has once again showcased its strong product strength and service capabilities to the global pharmaceutical community. As a global chemical cross-border trading service platform, ECHEMI will continue to leverage its advantages in the pharmaceutical industry, promoting the high-quality development of China's pharmaceutical industry and helping enterprises integrate into the global industrial chain. We believe that in the future development, ECHEMI will continue to innovate and pursue excellence, contributing more to the prosperity and development of the pharmaceutical industry.

Reviewing this exhibition, we not only see the prosperity and development of the pharmaceutical industry, but also ECHEMI's outstanding performance in it. This exhibition not only provided a platform for pharmaceutical companies to exchange and cooperate, but also inspired people's infinite expectations for the future of the pharmaceutical industry. We believe that with the joint efforts of excellent companies like ECHEMI, China's pharmaceutical industry will surely usher in an even more brilliant tomorrow.